Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q3 2023 · 10-Q
Revenue$16.02M$16.02M+22.8% vs Q3 2022 Net Income-$1.06M-$1.06MN/M vs Q3 2022 EPS Diluted-$0.13-$0.13N/M vs Q3 2022 Gross Profit$14,273,599+32.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flowderived$1,064,138N/M Free Cash Flowderived$893,818N/M Margins · derivedGross margin89.1%+6.2 pt vs Q3 2022
Operating margin-5.7%+19.1 pt vs Q3 2022
Net margin-6.6%+4.7 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 13, 2023 · 44 d after period end